CARL Stock Analysis: Buy, Sell, or Hold?
CARL - Carlsmed, Inc. Common Stock
$10.20
0.03 (0.29%)
▲
5d:
-12.97%
30d:
+12.21%
90d:
-21.48%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When CARL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CARL is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CARL is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CARL is currently trading at $10.20, which is considered fair relative to its 30-day fair value range of $9.35 to $11.54.
Technical Outlook: Technically, CARL is in a downtrend. The price is currently testing key support at $10.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.40 (+80.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CARL is in a downtrend. The price is currently testing key support at $10.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.40 (+80.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$9.35 -
$11.54
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 80.4% below Wall St target ($18.40)
- WARNING: Recommendation downgraded due to -13.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$9.35 -
$11.54
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.16
Resistance Level
$13.01
Current Trend
Downtrend
Technical data as of
Jun 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.11
Wall Street Target
$18.40
(+80.4%)
Revenue Growth (YoY)
58.2%
Profit Margin
-57.8%
Share & Embed Analysis
Last updated: June 03, 2026 5:05 PM ET
Data refreshes hourly during market hours. Next update: 6:05 PM
Data refreshes hourly during market hours. Next update: 6:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARL showing a specific setup today?
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$263 | 62 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 55 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$113 | 60 BUY |